Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting

American Journal of Neuroradiology

Volumn 17, Issue 5, 1996, Pages 831-840

  Bruening, Roland ^a,b   Kwong, Ken K ^a   Vevea, Mike J ^a   Hochberg, Fred H ^a   Cher, Lawrence ^a   Harsh IV, Griffith R ^a   Niemi, Pekka T ^a   Weisskoff, Robert M ^a   Rosen, Bruce R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Blood; Brain; Flow studies; Magnetic resonance; Neoplasms; Volume

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN TUMOR; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR DIAGNOSIS;

ADULT; BLOOD VOLUME; BRAIN; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; DRUG COMBINATIONS; ECHO-PLANAR IMAGING; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM; GADOLINIUM DTPA; GLIOMA; HUMANS; IMAGE ENHANCEMENT; INJECTIONS, INTRAVENOUS; MALE; MEGLUMINE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029887993     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Villringer A, Rosen BR, Belliveau J, et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988;6:164-174
2. Duyn JH, van Gelderen P, Barker P, Frank JA, Mattay VS, Moonen CT. 3D bolus tracking with frequency-shifted BURST MRI. J Comput Assist Tomogr 1994;18:680-687
3. Guckel F, Brix G, Rempp K, Deimling M, Rother J, Georgi M. Assessment of cerebral blood volume with dynamic susceptibility contrast enhanced gradient-echo imaging. J Comput Assist Tomogr 1994;18:344-351
4. Moonen CT, Barrios FA, Zigun JR, et al. Functional brain MR imaging based on bolus tracking with a fast T2*-sensitized gradient-echo method. Magn Reson Imaging 1994;12:379-385
5. Albert MS, Huang W, Lee JH, Patlak CS, Springer CS. Susceptibility changes following bolus injections. Magn Reson Med 1993;20:700-708
6. Maeda M, Itoh S, Kimura H, et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology 1993;189:233-238
7. Maeda M, Itoh S, Ide H, et al. Acute stroke in cats: comparison of dynamic susceptibility-contrast MR imaging with T2- and diffusion-weighted MR imaging. Radiology 1993;189:227-232
8. Rosen BR, Belliveau JW, Aronen HJ, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991;22:293-299
9. Edelman RR, Mattle HP, Atkinson DJ, et al. Cerebral blood flow: assessment with dynamic contrast-enhanced T2* weighted MR imaging at 1.5 T. Radiology 1990;176:211-220
10. Liu G, Sobering G, Olson AW, van Gelderen P, Moonen CT. Fast echo-shifted gradient-recalled MRI: combining a short repetition time with variable T2* weighting. Magn Reson Med 1993;30:68-75
11. Morvan D, Leroy-Willig A, Malgouyres A, Cuenod CA, Jehenson P, Syrota A. Simultaneous temperature and regional blood volume measurements in human muscle using an MRI fast diffusion technique. Magn Reson Med 1993;29:371-377
12. Zigun JR, Frank JA, Barrios FA, et al. Measurement of brain activity with bolus administration of contrast agent and gradient-echo MR imaging. Radiology 1993;186:353-356
13. Brasch RC. New directions in the development of MR imaging contrast media. Radiology 1992;183:1-11
14. Tzika AA, Massoth RJ, Ball WS, Majumdar S, Dunn RS, Kirks DR. Cerebral perfusion in children: detection with dynamic contrast-enhanced T2*-weighted MR images. Radiology 1993;187:449-458
15. Aronen H, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41-51
16. Hacklaender T, Hofer M, Paselk C, Moedder U. Functional imaging of the brain with low dose Gd-DTPA and turbo flash sequences. Roentgenfortschritte 1993;158:348-354
17. Dean BL, Lee C, Kirsch JE, Runge VM, Dempsey RM, Pettigrew LC. Cerebral hemodynamics and cerebral blood volume: MR assessment using gadolinium contrast agents and T1-weighted turbo-FLASH imaging. AJHR Am J Neuroradiol 1992;13:39-48
18. Schwarzbauer C, Syha J, Haase A. Quantification of regional blood volumes by rapid T1 mapping. Magn Reson Med 1993;29:709-712
19. Cohen FM, Kuwatsuru R, Shames DM, et al. Contrast-enhanced MR estimation of altered capillary permeability in experimental mammary carcinomas after x-irradiation. Invest Radiol 1994;29:970-977
20. Krueck WG, Schmiedl UP, Maravilla KR, Spence AM, Starr FL, Kenney J. MR assessment of radiation-induced blood-brain barrier permeability changes in rat glioma model. AJNR Am J Neuroradiol 1994;15:625-632
21. Zigun JR, Frank JA, Barrios FA, et al. Measurement of brain activity with bolus administration of contrast agent and gradient-echo MR imaging. Radiology 1993;186:353-356
22. Rosen BR, Belliveau JW, Buchbinder BR, et al. Contrast agents and cerebral hemodynamics. Magn Reson Med 1991;19:285-292
23. Reith W, Forsting M, Vogler H, Heiland S, Saror K. Early MR detection of experimentally induced cerebral ischemia using magnetic susceptibility contrast agents: comparison between gadopentate dimeglumine and iron oxide particles. AJNR Am J Neuroradiol 1995;16:53-60
24. Moseley ME, Chew WM, White DL, et al. Hypercarbia-induced changes in cerebral blood volume in the cat: a 1H and intravascular contrast agent study. Magn Reson Med 1992;23:21-30
25. Alavi JB, Alavi A, Chaluk J, et al. Positron emission tomography in patients with glioma. Cancer 1988;62:1074-1078
26. Davis WK, Boyko OB, Hoffmann JM, et al. (18 F) Fluoro-2-deoxyglucose positron emission tomography: correlation of gadolinium-enhanced MR imaging of central nervous systems neoplasia. AJNR Am J Neuroradiol 1993;14:515-523
27. DiChiro G, Fulham MJ. Virchows shackles: can PET-FDG challenge tumor histology? (commentary). AJNR Am J Neuroradiol 1993;14:424-527
28. Forsting M, Albert FK, Kunze S, Adams HP, Zenner D, Sartor K. Extirpation of glioblastomas: MR and CT follow-up of residual tumor and regrowth patterns. AJNR Am J Neuroradiol 1993;14:77-87
29. Rozental JM, Levine RL, Nickles RJ, Dobkin JA. Glucose uptake by gliomas after treatment: a PET study. Arch Neurol 1989;46:1302-1307
30. Schifter T, Hoffman JM, Hanson MW, et al. Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors. J Comput Assist Tomogr 1993;17:509-516
31. Ogawa T, Uemura K, Shishido F, et al. Changes of cerebral blood flow, and oxygen and glucose metabolism following radiochemotherapy of giomas: a PET study. J Comput Assist Tomogr 1988;12:290-297
32. Glanz MJ, Hoffman JM, Coleman RE, Friedman AH, et al. Identification of early recurrence of primary central nervous system tumors by 18F fluorodeoxyglucose positron emission tomography. Ann Neurol 1991;29:347-355
33. Patronas NJ, DiChiro G, Kufta C, et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985;62:816-822